Attachment of Fusobacterium nucleatum to various oral surfaces is mediated by several adhesins anchored on its outer surface. Monoclonal antibodies (MAbs) were prepared and used to identify the putative galactosebinding adhesin of F. nucleatum PK1594. Four unique MAbs, 8G7, 26B9, 28G11, and 29D4, were isolated on the basis of their ability to inhibit coaggregation of F. nucleatum PK1594 with Porphyromonas gingivalis PK1924. All four MAbs were also capable of inhibiting galactose-inhibitable interactions of F. nucleatum PK1594 with other oral gram-negative bacteria and with erythrocytes. Preincubation of F. nucleatum PK1594 with MAb 26B9 or its Fab fragments at concentrations lower than 1 g/ml resulted in complete inhibition of coaggregation with P. gingivalis PK1924 or hemagglutination. F. nucleatum PK1594 surface components prepared by mild sonication or by extracting whole cells with detergents were subjected to Western blot analysis. None of the MAbs were able to recognize any polypeptide in these experiments. Therefore, detergent extracts of F. nucleatum PK1594 surface components were subjected to three experimental procedures: (i) separation by ion-exchange chromatography and testing of fractions for reaction with MAb 26B9 in an enzyme-linked immunosorbent assay (ELISA), (ii) lactose-Sepharose affinity chromatography and testing of the lactose eluate in ELISA with MAb 26B9, and (iii) immunoseparation with either MAb 26B9 or 8G7. Collectively, the results suggest that the putative adhesin is a 30-kDa outer membrane polypeptide which mediates the coaggregation with P. gingivalis PK1924 as well as other galactose-sensitive interactions of F. nucleatum PK1594.
tions (35) . Freshly grown F. nucleatum PK1594 cells were washed, resuspended in 1 M NaCl with 3 mM EDTA, and incubated for 48 h at 4°C with gentle agitation. Cells were sonicated at five-sixths of maximum power in a sonicator (MSE Scientific, Leicester, England) for 1 min in an ice bath and allowed to cool for 1 min. This treatment was repeated for six consecutive cycles. Most of the cells remained whole and were removed by differential centrifugation (9,700 ϫ g for 10 min). The cell-free supernatant was centrifuged at 190,000 ϫ g for 2 h at 4°C, and the pellet enriched with F. nucleatum surface components was resuspended in CAB, adjusted to a protein concentration of 3 mg/ml (Bio-Rad Protein Assay; Bio-Rad Laboratories, Munich, Germany), and used as an antigen for preparing polyclonal antibodies and MAbs. The presence of adhesin activity in the surface component suspension was ensured by mixing 10 l with 50 l of P. gingivalis PK1924 suspensions. The observed aggregation was inhibited by 60 mM galactose.
Preparation of F. nucleatum PK1594-specific polyclonal antibodies. An 8-week-old New Zealand rabbit was immunized with the F. nucleatum PK1594 surface component fraction by repeated intravenous injections (44) . On day 0, preimmune serum was collected, and this served as a control throughout all experiments. The animal was then immunized with 3 mg of proteins of surface components followed by the same amount of antigen weekly. After 10 injections, serum was collected and tested for the presence of adhesin-specific antibodies by its ability to inhibit coaggregation between F. nucleatum PK1594 and P. gingivalis PK1924.
Preparation of MAbs that inhibit coaggregation. Coaggregation-blocking MAbs were raised by the method described previously with minor modifications (42, 43) . Five BALB/c female mice, 2 months old, were immunized with F. nucleatum PK1594 adhesin-containing surface components. On day 0, each animal received 100 g of surface component fraction in Freund complete adjuvant by subcutaneous injections. Every 2 to 3 weeks thereafter, the mice received subcutaneous booster injections containing 100 g of antigen in Freund incomplete adjuvant. One week after administration of the sixth booster, the sera from the animals were tested for the presence of coaggregation-blocking antibodies. The spleen cells of the mouse producing the highest titer of coaggregation-blocking antibodies were fused with myeloma line NS0. Supernatants from the resulting hybridoma cell lines were screened for the ability to secrete antibodies which inhibit coaggregation as described previously (38, 42, 43) . Briefly, 30 l of hybridoma supernatant was incubated with 30 l of F. nucleatum PK1594 (5 ϫ 10 7 cells/ml) in 96-well microtitration trays. Trays were prepared in duplicate. After 1 h of incubation, an equal volume and concentration of P. gingivalis PK1924 suspension was added to one set of trays, and a similarly prepared A. israelii PK16 suspension was added to the other set. The contents of the trays were mixed vigorously for 10 s with a microtiter tray mixer (Titertek; Flow Laboratories, Irvine, United Kingdom) and observed for the presence of coaggregates. Wells containing an evenly turbid bacterial suspension without visible coaggregates were retested and chosen for further cloning. Positive cultures were cloned by limiting dilution, and the supernatants were assayed as described above. Positive clones were injected into the peritoneal cavities of BALB/c mice previously primed with pristane (Sigma Chemical Co., St. Louis, Mo.). Ascitic fluid was collected, and the MAbs were purified by using protein G columns according to instructions of the manufacturer (Pharmacia Fine Chemicals, Uppsala, Sweden). The eluted fractions were tested for the ability to inhibit the respective coaggregation interactions. Isotypes were determined with the Immuno Type Mouse Monoclonal Antibody Isotyping Kit (Sigma Chemical Co.).
Preparation of Fab fragments. A purified MAb which exhibited high blocking activity with P. gingivalis PK1924 was chosen for the preparation of Fab fragments. MAb 26B9 was partially digested by adding activated papain to a MAb solution (0.15 mg/ml) at a ratio of 1:20 and incubated for 1 h at 37°C. The Fab fractions were purified with a DEAE-Sephacel column (Pharmacia Fine Chemicals) (43) . Fractions of 0.5 ml were collected and dialyzed extensively, and the purity of the Fab fragments was confirmed by unreduced sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) and silver staining.
Quantitative coaggregation assay. The inhibition of coaggregation by MAbs and Fab fragments was quantitated by a spectrophotometric assay (43) . Freshly grown F. nucleatum PK1594, A. actinomycetemcomitans JP2, and P. gingivalis PK1924 were harvested, washed three times in CAB, and adjusted to a concentration of 5 ϫ 10 7 cells/ml. A total of 300 l of F. nucleatum cell suspension was incubated with 300 l of MAbs or purified Fab fragments at appropriate concentrations for 60 min with mild agitation. Then, 300 l of the respective coaggregation partner strain was added, and the contents of the test tubes were vigorously mixed for 10 s. The test tubes were centrifuged at 7 ϫ g for 2 min (Sorval RT6000B; DuPont Instruments, Wilmington, Del.), and the optical density of the supernatant at 400 nm was determined. Controls consisted of F. nucleatum or the respective coaggregation partner cell suspensions and either normal mouse immunoglobulin G (IgG) or CAB. Data are expressed as the mean results from at least two experiments carried out in triplicate.
Hemagglutination assay. Visual assays for bacterium-mediated hemagglutination were performed in 96-well round-bottom microtiter trays at room temperature (15) . Freshly obtained human group O erythrocytes were washed three times in phosphate-buffered saline and adjusted to a 2% (vol/vol) cell suspension. A cell suspension of 50 l of erythrocytes was added to 50 l of twofold serial dilutions of F. nucleatum PK1594 cells and mixed for 1 min. Hemagglutinating activity was observed after 2 h of incubation. For inhibition assays, twofold serial dilutions of potential inhibitors were added to F. nucleatum PK1594 suspensions and incubated for 1 h before addition of the erythrocytes. All tests were performed in duplicate and repeated twice.
Immunological methods. The presence of adhesin molecules in surface components and in fractions of extracted outer membrane proteins was tested by adsorbance onto 96-well microtiter plates (10 to 15 g/well) as solid-phase antigens for enzyme-linked immunosorbent assays (ELISA) with alkaline phosphatase-conjugated anti-mouse IgG (12) .
For Western blot analysis, surface components of F. nucleatum (20 g/well) were separated by SDS-PAGE (21) , and the resolved polypeptides were transferred onto nitrocellulose membranes (39) . The membrane was blocked for nonspecific binding, treated overnight with primary antibody, and reacted with an appropriate secondary antibody conjugated to alkaline phosphatase. After 1 h of incubation, alkaline phosphatase substrate (BCIP [5-bromo-4-chloro-3-indolylphosphate]-nitroblue tetrazolium) (Sigma) was added according to the manufacturer's instructions.
Extraction of outer membrane proteins. Freshly grown F. nucleatum PK1594 cells were harvested and washed three times in CAB. Cells were resuspended (1:10, wt/vol) in extraction buffer consisting of 2% Triton X-100 (t-octylphenoxypolyethoxyethanol), 10 mM MgCl 2 in 10 mM HEPES (Sigma) (pH 7.4) (3), and a mixture of protease inhibitors consisting of N-tosyl-L-phenylalanine chloromethyl ketone (TPCK), Na-p-tosyl-L-lysine chloromethyl ketone (TLCK), N-CBZ-L-phenylalanine chloromethyl ketone (ZPCK), iodoacetamide, and phenylmethylsulfonyl fluoride at 2 mM each (Sigma). The suspension was incubated overnight at 4°C with end-over-end rotation. The above-described extraction procedure was repeated three times, and all extracts were pooled. Cells were removed by differential centrifugation, and the supernatant was passed through a 0.2-m-pore-size filter (Sterile Acrodisc Syringe Filter; Gelman Sciences). The supernatant was then dialyzed against 10 mM Tris-HCl containing 0.002% Triton and 0.01% NaN 3 . The presence of adhesin was determined by ELISA.
Immunoseparation of the galactose-binding adhesin. Ten milligrams of the F. nucleatum outer membrane protein extract was incubated with 0.12 mg of purified 26B9 for 16 h at 4°C with end-over-end rotation. The antigen-antibody complex was separated from the protein mixture by using an IgG affinity protein G column (Pharmacia Fine Chemicals) according to the manufacturer's instructions. The eluate was collected in fractions of 1 ml and subjected to SDS-PAGE and Western blot analysis. F. nucleatum outer membrane-specific rabbit polyclonal antibody was used as a primary antibody, and the nitrocellulose sheets were processed as described above. Controls consisted of similarly prepared nitrocellulose membranes developed with (i) preimmune serum as a primary antibody or (ii) anti-mouse IgG as a secondary antibody without a primary antibody.
Ion-exchange chromatography. The 2% Triton X-100 extract was applied to a DEAE-Sephacel column (2.5 by 10 cm) (Pharmacia Fine Chemicals) equilibrated with Tris-HCl buffer (10 mM Tris-HCl [pH 7.8] containing 0.002% Triton X-100). Extracted outer membrane proteins were loaded at a flow rate of 0.3 ml/min. The bound fraction was eluted with a 100-ml (total) linear gradient of 0 to 1 M NaCl. Fractions of 1 ml were collected and assayed for adhesin presence by ELISA. Positive fractions were extensively dialyzed and examined by SDS-PAGE and silver staining (5) . For further isolation, positive fractions were pooled and treated with 1% CHAPS {3-[(cholamidopropyl)-dimethylammonio]-1-propanesulfonate} (Sigma). Separation of proteins by ion-exchange chromatography and assays of fractions for the presence of adhesins were carried out as described above.
Lactose affinity chromatography. Affinity chromatography was performed by applying 20 ml of a 1% CHAPS extract of F. nucleatum PK1594 envelope proteins (1.6 mg of protein/ml) to a column of lactose covalently bound to Sepharose beads (Sigma), which was equilibrated with 0.01 M phosphate buffer (pH 7.2) containing 0.5 M NaCl and 0.02% CHAPS (41) . After extensive washing, bound material was eluted by 0.2 M lactose in the same buffer. Fractions of 1 ml were collected and tested by ELISA with MAb 26B9 as a probe. Positive eluted fractions were pooled, dialyzed against 10 mM Tris-HCl (pH 7.8), concentrated (10ϫ) by lyophilization, and examined by SDS-PAGE and silver staining.
that the MAbs are adhesin specific and that their inhibitory effect is due to their recognition of epitopes close to the adhesin's active site, Fab fragments of MAb 26B9 were prepared and tested for coaggregation inhibition (Fig. 1) . Complete inhibition of the coaggregation between F. nucleatum PK1594 and P. gingivalis PK1924 was obtained by MAb 26B9, or its Fab fragments, at a concentration lower than 1 g of protein/ml (Fig. 1A) .
F. nucleatum PK1594 exhibits other galactose-inhibitable interactions. The coaggregation interaction of F. nucleatum PK1594 with A. actinomycetemcomitans JP2 was found to be equally inhibited by 5 mM galactose, lactose, or N-acetylgalactosamine (data not shown). Similarly, F. nucleatum PK1594-mediated hemagglutination was also inhibited by galactose (6 mM) and its derivatives (Table 2) , while other carbohydrates or amino acids were ineffective. These findings are in agreement with the sugar specificity of the F. nucleatum PK1594-P. gingivalis PK1924 interaction previously reported by Kolenbrander and Andersen (23) . Therefore, the effect of MAb 26B9 or its Fab fragments on these interactions was tested. The coaggregation with A. actinomycetemcomitans JP2 was completely inhibited at an antibody concentration lower than 0.5 g/ml (Fig. 1B) , and hemagglutination was inhibited at a MAb concentration of 0.75 g/ml and a Fab concentration of 0.5 g/ml ( Table 2) . Similar results were obtained with MAb 8G7 (not shown), while MAb 5H11 had no effect. These results suggest that hemagglutination and galactose-sensitive coaggregations are mediated by the same adhesin.
Identification of a putative galactose-binding adhesin. MAbs 26B9 and 8G7 were used to identify the galactose-sensitive adhesin. Sonicated fragments of outer membrane proteins extracted with 2% Triton X-100 were resolved by SDS-PAGE, under either reducing or nonreducing conditions, followed by Western blot analysis. The MAbs did not recognize any of the F. nucleatum outer membrane polypeptides transferred onto the nitrocellulose membrane (data not shown). Therefore, the putative adhesin was immunoseparated from the 2% Triton X-100 extract by using MAbs and an antibody affinity-protein G column. Three distinct protein G columns were used with the following three incubation mixtures: (i) ascitic fluid of MAb 26B9 with bacterial extract, (ii) MAb 26B9 with bacterial extract, and (iii) as a control, MAb 26B9 without bacterial extract. The resulting eluates were subjected to Western blot analysis, using F. nucleatum-specific polyclonal antibodies as probes (Fig. 2) . Lanes 1 and 2 of Fig. 2 , which contain eluates from columns (i) and (ii) respectively, contain two polypeptides with molecular masses of 28 and 30 kDa, in addition to the MAb molecule. These proteins do not appear in lane 3 of Fig. 2 , which contains eluate from column (iii), on which only ascitic fluid of MAb 26B9 was applied. The two polypeptides are of F. nucleatum PK1594 origin, as they react with anti-F. nucleatum rabbit serum and are not recognized by anti-mouse IgG without primary antibody or preimmune serum (Fig. 2B  and C) . Similar results were obtained by using MAb 8G7 (not shown).
For further analysis, the 2% Triton X-100 extract was subjected to ion-exchange chromatography. Nearly 50% of the extracted proteins did not bind to the column under these conditions. Unbound and NaCl-eluted fractions were tested for the presence of the putative galactose-binding adhesin by ELISA, using MAb 26B9 as a probe (Fig. 3) . MAb 5H11, which is specific for another F. nucleatum PK1594 adhesin, was used as a negative control. The fraction of unbound proteins tested negative with both MAbs in ELISA. The putative galactose-sensitive adhesin was eluted by the NaCl gradient in two peaks. The anterior part of the first peak shown in Fig. 3 (fractions 110 to 117) was positive only with MAb 26B9, indicating enrichment of the galactose-sensitive adhesin, whereas other fractions reacted with both MAbs and were not used in the present study. SDS-PAGE and silver staining revealed that fractions 110 to 117 contained several polypeptide bands
FIG. 1. Inhibition of coaggregation between F. nucleatum PK1594 and P. gingivalis PK1924 (A) or A. actinomycetemcomitans JP2 (B) by MAb 26B9 (E) or Fab fragments (F).
Neither normal mouse IgG nor MAb 5H11, specific for the adhesin which mediates coaggregation with A. israelii PK16, showed any inhibition at the maximum IgG concentration tested (50 g of protein/ml). (data not shown). Therefore, these fractions were pooled and treated with 1% CHAPS in Tris-HCl buffer to further separate undissociated polypeptides. This CHAPS extract was subjected to ion-exchange chromatography and eluted with an NaCl gradient as described above to give a single peak (not shown). All eluted fractions were analyzed by SDS-PAGE, and the presence of the putative adhesin in the fractions was tested with MAb 26B9 in ELISA. Fractions obtained from the anterior part of the eluted peak are shown in Fig. 4 . Lanes 1 through 8 were loaded with 30-l samples of each fraction, which contained 0.6 to 2.0 g of protein. Subjecting 50-l samples of these fractions to ELISA with MAb 26B9 as a probe gave relative absorbance values (at 405 nm) of 0.19, 0.28, 0.33, 0.32, 0.50, 0.51, 0.58, and 0.59 respectively. These ELISA values correlate with the intensity of the silver-stained 30-kDa polypeptide band (Fig. 4) . None of the fractions in Fig. 4 reacted with MAb 5H11. The fractions contained an additional 51-kDa polypeptide which is unrelated to the putative galactose-binding adhesin, since this polypeptide did not correlate with the ELISA values and was also present in many other fractions which tested negative in ELISA with MAb 26B9 (data not shown). The fractions which tested positive with MAb 26B9 in ELISA were subjected to Western blot analysis. None of the MAbs reacted with any polypeptides transferred onto nitrocellulose membranes.
Fractions containing the putative adhesin obtained by ionexchange chromatography (see above) were tested for inhibition of coaggregation. These adherence-blocking experiments were inconclusive, since complete inhibition was not observed in any fraction. Therefore, galactose-binding activity of the putative adhesin was demonstrated by applying detergent extracts (1% CHAPS), which tested positive with MAb 26B9 in ELISA, to a column of lactose covalently bound to agarose beads. Most of the applied material did not bind to the affinity column, while maintaining high ELISA values when tested with the same MAb. Only a small fraction of extracted proteins was retained on the column and eluted by 200 mM lactose. This fraction tested positive with MAb 26B9 in ELISA (Fig. 5) . SDS-PAGE and silver staining of the unbound detergent extract and the fraction eluted by lactose which was concentrated 10-fold are shown in Fig. 6 . The unbound material contains many polypeptide bands, while the lactose-eluted fraction contains at least two polypeptide bands, one of which migrates at 30 kDa.
DISCUSSION
F. nucleatum is most closely correlated with gingivitis and subsequent irreversible tissue breakdown, and it is also one of the most common periopathogenic species associated with infections of other human organs (32) . F. nucleatum participates in both adhesion and coaggregation reactions and plays a key role in colonization of the periodontal milieu as well as in maturation of the dental plaque (16, 22, 28) .
Attachment of F. nucleatum PK1594 to various exposed oral surfaces is mediated by several proteinaceous adhesins, one of which is a galactose-binding adhesin which mediates attachment to periopathogenic bacteria and to erythrocytes. The (Fig. 3) were pooled, treated with 1% CHAPS, subjected to ion-exchange chromatography, and eluted with an NaCl gradient, resulting in a single peak. Lanes 1 through 8, 30-l samples of fractions from the anterior part of the eluted peak (0.6 to 2.0 g of protein per lane, respectively). Lane 9, sample applied to the column. Molecular masses in kilodaltons are shown on the right.
galactose-binding adhesin may also have an important role in the interaction with other host cells. In several other studies, it was suggested that fusobacterial galactose-binding proteins mediate interactions with epithelial cells, fibroblasts, and lymphocytes (30, 40) as well as hemagglutination (13, 31) . NAcetylgalactosamine inhibits polymorphonuclear leukocyte activation by F. nucleatum, as well as phagocytosis and killing (30, 36) .
The identification of the galactose-binding adhesin of F. nucleatum PK1594 was approached by preparing adhesin-specific MAbs. To obtain MAbs specific for unidentified adhesins, outer membrane components which possessed adhesin activity served as an antigen. Blocking of biological activity was used as the sole criterion for selecting antibody-producing cell lines. This screening strategy was previously used to characterize and identify (i) two distinct fimbria-associated adhesins of Porphyromonas loescheii PK1295 which mediate coaggregation with Streptococcus sanguis 34 and A. israelii PK14, respectively (43), (ii) a membrane-associated, rhamnose-sensitive 155-kDa adhesin of Capnocytophaga ochracea ATCC 33596 (42) , and (iii) a NeuAc-sensitive 150-kDa adhesin of Capnocytophaga gingivalis DR2001 (38) .
The specificity of the antibodies towards the galactose-sensitive adhesin of F. nucleatum PK1594 was demonstrated by use of the Fab fragments of MAb 26B9, which exhibit effective inhibition at very low concentration. MAbs which inhibited coaggregation with P. gingivalis PK1924 also inhibited other galactose-sensitive interactions, including coaggregation with A. actinomycetemcomitans JP2 and hemagglutination. These interactions were equally sensitive to galactose, lactose, and N-acetylgalactosamine, similar to the previously described interaction with P. gingivalis PK1924 (23) . The functional similarity among the adhesin activities in conjunction with identical immunologic reactivity strongly argues for the presence of a single galactose-sensitive F. nucleatum PK1594 adhesin. Therefore, it is reasonable to assume that this galactose-sensitive adhesin mediates not only those interactions tested by us but also coaggregation interactions of F. nucleatum PK1594 with other potential pathogens, such as species of Treponema, Selenomonas, and Helicobacter, which were all found to be galactose inhibitable (1, 26, 29) .
Another aspect of this adhesin is its possible role in mediating attachment to mammalian cells. The galactose-sensitive hemagglutination reported here may represent a more general phenomenon in which F. nucleatum PK1594 interacts with other host cells and salivary components in the acquired pellicle via the galactose termini of host macromolecules, as reported for other strains of F. nucleatum (14, 30, 31, 34) . The galactose-sensitive adhesin may contribute to the pathogenicity of F. nucleatum PK1594 by helping both in anchoring other, poorly adhering pathogenic bacteria onto the periodontal microenvironment and in attachment of fusobacteria to the sulcular epithelium and eventually to other exposed host cells and macromolecules (2) .
Galactose-binding adhesins of other F. nucleatum isolates have been characterized in previous studies. A galactose-binding lectin from F. nucleatum FN-2, with a mass of 300 to 330 kDa, was identified by its ability to bind and elute from asialofetuin covalently coupled to Sepharose beads (34) . Kinder and Holt (19, 20) found that the galactose-sensitive coaggregation between the monkey oral strains F. nucleatum T18 and P. gingivalis T22 is inhibited by an outer membrane fraction of the former strain. This fraction was enriched for several proteins, including a major 42-kDa outer membrane protein. Fab fragments of antibody raised against this protein inhibited coaggregation by only 35% at a concentration of 500 g/ml. The high concentration of polyclonal antisera needed to partially inhibit coaggregation may argue for an adhesin with spatial proximity to the 42-kDa outer membrane protein rather than one that is part of this protein.
The MAbs described in the present study did not recognize any of the F. nucleatum PK1594 outer membrane proteins transferred to nitrocellulose membranes. It is not uncommon that MAbs interact with secondary or tertiary polypeptide structures which are obliterated or modified by gel electrophoresis and/or electroblotting. Therefore, the identification of the F. nucleatum PK1594 adhesin was approached indirectly. A 30-kDa polypeptide, extracted from the surface of the bacterium, was identified as the putative galactose-binding adhesin in three experimental setups. that MAb 26B9 or 8G7 binds two polypeptides of 28 and 30 kDa extracted from the bacterial envelope. (ii) By ion-exchange chromatography we were able to isolate the 30-kDa polypeptide in fractions that exhibited a significant and specific interaction with MAb 26B9 but not with MAb 5H11. (iii) The lactose eluant from the affinity column contains both the 30-kDa polypeptide and an antigen which reacts in ELISA with MAb 26B9. This may indicate that the 30-kDa polypeptide bears the galactose-binding site. The fact that only a small fraction of the putative adhesin molecules were bound to the lactose residue may suggest that binding affinity to the column under the experimental conditions used was low. It is also possible that only part of the solubilized protein is in its active form and capable of binding the galactose-containing moiety. This may provide an explanation for why fractions obtained by ion-exchange chromatography which contained the 30-kDa polypeptide had an undetectable inhibitory effect on the coaggregation between F. nucleatum PK1594 and P. gingivalis PK1924.
We also suggest that the two adhesin activities, i.e., the galactose-inhibitable adhesin, which reacts with MAb 26B9, and the other adhesin, which reacts with MAb 5H11, are found on two separate polypeptides probably organized in a complex on the outer surface of the microorganism. This hypothesis is based on the following observations. (i) High concentrations of MAbs 5H11 and 19F2 have no effect on the coaggregation with P. gingivalis PK1924, and high concentrations of MAbs 26B9, 8G7, 28G11, and 29D4 have no effect on the coaggregation with A. israelii PK16. (ii) Using a two-step extraction, we were able to isolate fractions containing the putative galactose-binding adhesin only. (iii) Except for a few fractions shown in Fig.  4 , all other fractions, including those obtained from various detergent extracts, contained both adhesins. (iv) Immunoseparation experiments using MAb 5H11 (similar to those performed with MAb 26B9 and shown in Fig. 2 ), yielded multiple polypeptide bands, including a band(s) migrating at 30 kDa (data not shown).
Isolation of the genes encoding the putative 30-kDa galactose-binding adhesin and the adhesin recognized by MAb 5H11 will be necessary to confirm the identification and spatial arrangement of these molecules as well as to perform structure-function studies in order to explore their role in coaggregation.
